Flavors and E-cigarette Effects in Adolescent Smokers


This study is to examine if inhaled doses of menthol that produce low and high cooling effects change the appeal of e-cigarettes containing low and high doses of nicotine in adolescent smokers. The hypothesis is that the combination of nicotine and menthol, when compared with menthol or nicotine alone, will result in greater increase in liking of an e-cigarette and greater reduction in nicotine withdrawal.

Study Start Date

October 2014

Estimated Completion Date

August 2018


  • Other: High Dose Menthol
  • Drug: Nicotine
  • Other: Low Dose Menthol


  • Psychiatry: Substance Abuse
  • Family Medicine: Substance Abuse
  • Nurse Practitioner: Substance Abuse

MeSH Terms

  • Low Dose Menthol
  • Tobacco Use Disorder

Study ID

Yale University -- 1307012312



Trial ID


Study Type


Trial Phase

Phase 1

Enrollment Quota



Yale University

Inclusion Criteria

  • Ages 16-19 years
  • Able to read and write
  • Cigarette smoker
  • Use of e-cigarettes in the past 30 days

Exclusion Criteria

  • Seeking smoking cessation treatment
  • Current/lifetime criteria for dependence on another psychoactive substance as diagnosed using the Diagnostic Interview Schedule for Children-IV (DISC-IV)
  • Daily use of alcohol or marijuana or use of any other drugs including cocaine, opiates, stimulants
  • Regular use of psychoactive drugs including anxiolytics, antidepressants and other psychostimulants
  • Current or past history of psychosis or other psychiatric diagnosis such as major depression
  • Any significant current medical condition




16 Years to 19 Years

Accepts Healthy Volunteers

Accepts Healthy Volunteers

Study Locations and Contact Information (1)

Study Location Distance Name Phone Email
CMHC - New Haven, Connecticut 17.3 miles Amanda Liss BA 203-974-7418 amanda.liss@yale.edu

ClinicalTrialsLocator.com provides clinical trial listings in an easy to view format. All clinical trial information is pulled directly from ClinicalTrials.gov. This website does not guarantee acceptance into any clinical trial, and is not responsible for adverse events that may be incurred from a clinical trial.